Charumathi Sabanayagam

Prof. Charumathi Sabanayagam

Singapore Eye Research Institute
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Ophthalmology
Verified
Journal Article
Closed access
ZTZhen Ling Teo
Zhen Ling Teo
YTYih-Chung Tham
Yih-Chung Tham
MYMarco Yu
Marco Yu
MCMiao Li Chee
Miao Li Chee
TRTyler Hyungtaek Rim
Tyler Hyungtaek Rim
CCChing-Yu Cheng
Ching-Yu Cheng

12 December 2017 in JAMA
Verified
Journal Article
Open access
PDF file
DTDaniel Shu Wei Ting
Daniel Shu Wei Ting
CCCarol Yim-Lui Cheung
Carol Yim-Lui Cheung
GLGilbert Lim
Gilbert Lim
GTGavin Siew Wei Tan
Gavin Siew Wei Tan
NQNguyen D. Quang
Nguyen D. Quang
TWTien Yin Wong
Tien Yin Wong
By 2040, it is projected that approximately 600 million people will have diabetes, with one-third expected to have diabetic retinopathy.1-3 Screening for diabetic retinopathy, coupled with timely referral and treatment, is a universally accepted strategy for blindness prevention.2 However, programs for screening diabetic retinopathy are challenged by issues related to implementation, availability of human assessors, and long-term financial sustainability.2,4-7

30 September 2015 in Eye and Vision
Verified
Journal Article
Open access
PDF file
RLRyan Lee
Ryan Lee
TWTien Y. Wong
Tien Y. Wong
CSCharumathi Sabanayagam
Charumathi Sabanayagam
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a further one third of DR is vision-threatening DR, including diabetic macular edema (DME). The identification of established modifiable risk factors for DR such as hyperglycemia and hypertension has provided the basis for risk factor control in preventing onset and progression of DR. Additional research investigating novel risk factors has improved our understanding of multiple biological pathways involved in the pathogenesis of DR and DME, especially those involved in inflammation and oxidative stress. Variations in DR prevalence between populations have also sparked interest in genetic studies to identify loci associated with disease susceptibility. In this review, major trends in the prevalence, incidence, progression and regression of DR and DME are explored, and gaps in literature identified. Established and novel risk factors are also extensively reviewed with a focus on landmark studies and updates from the recent literature.

9 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SGSarah E. Graham
Sarah E. Graham
SCShoa L. Clarke
Shoa L. Clarke
KWKuan-Han H. Wu
Kuan-Han H. Wu
Stavroula KanoniStavroula Kanoni
Stavroula Kanoni
GZGreg J. M. Zajac
Greg J. M. Zajac
CWCristen J. Willer
Cristen J. Willer

31 May 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLifelines Cohort Study
Lifelines Cohort Study
MWMatthias Wuttke
Matthias Wuttke
VPV. A. Million Veteran Program
V. A. Million Veteran Program
YLYong Li
Yong Li
MLMan Li
Man Li
CPCristian Pattaro
Cristian Pattaro
Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic complications. Through trans-ancestry meta-analysis of genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replication (n = 1,046,070), we identified 264 associated loci (166 new). Of these, 147 were likely to be relevant for kidney function on the basis of associations with the alternative kidney function marker blood urea nitrogen (n = 416,178). Pathway and enrichment analyses, including mouse models with renal phenotypes, support the kidney as the main target organ. A genetic risk score for lower eGFR was associated with clinically diagnosed CKD in 452,264 independent individuals. Colocalization analyses of associations with eGFR among 783,978 European-ancestry individuals and gene expression across 46 human tissues, including tubulo-interstitial and glomerular kidney compartments, identified 17 genes differentially expressed in kidney. Fine-mapping highlighted missense driver variants in 11 genes and kidney-specific regulatory variants. These results provide a comprehensive priority list of molecular targets for translational research.

12 May 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AMAnubha Mahajan
Anubha Mahajan
CSCassandra N. Spracklen
Cassandra N. Spracklen
WZWeihua Zhang
Weihua Zhang
MNMaggie C. Y. Ng
Maggie C. Y. Ng
LPLauren E. Petty
Lauren E. Petty
AMAndrew P. Morris
Andrew P. Morris